Kos Pharmaceuticals, Inc (KOSP) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Kos Pharmaceuticals, Inc (KOSP)

An SI Board Since March 1997

Posts	SubjectMarks	Bans	Symbol
118	20	0	KOSP

Emcee: DD™	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
43	This thread needs some life. MIKE	Michael Young	-	3/3/2001
42	CORRECTED - Kos, DuPont seek OK from FDA Tu	Bipin Prasad	-	9/27/2000
41	Kos Pharmaceuticals Inc. (KOSP): The drugmaker said two new studies support the	Bipin Prasad	-	5/14/2000
40	This is the first time I have visited your site. I was trying to do some resear	vera haller	-	3/14/1998
39	From two analysts, dated earlier this year: Cowen, on a downgrade to neutral,	JerryR	-	3/5/1998
38	Niaspan prescriptions looking strong. On a pace to be up 60% in January vs. De	Michael Young	-	2/3/1998
37	I don't know about a buyout, but KOSP looks like a real opportunity at this	Michael Young	-	1/25/1998
36	Thanks, I saw the post on YHOO as well. 14 the trigger eh? Looking for 1mil+	Herb	-	1/23/1998
35	Saw it first on the leader board and checked YHOO. Some rummy posted a $22 dea	PanzerGeneral	-	1/21/1998
34	Who'd ya hear it from? Yahoo?	Herb	-	1/20/1998
33	I appreciate your response. Of course, if it pans out to be true (as ridiculou	aradu	-	1/19/1998
32	I've heard from 2 people that there is a buyout underway. If KOSP gaps to	PanzerGeneral	-	1/19/1998
31	Please does anybody know of any impending news? The stock really woke up on fr	aradu	-	1/19/1998
30	Likewise, Jeff. I thought the selloff was hugely overdone, and bought some yes	(Bob) Zumbrunnen	-	11/13/1997
29	Tom, If you read my entire post, that was exactly my point. Sure, earnings we	Jeff Briley	-	11/13/1997
28	The beating of earnings estimates was irrelevant. The make or break issue is s	Tom D	-	11/12/1997
27	Was just looking at First Call... noticed that KOSP actually beat estimates tod	Jeff Briley	-	11/12/1997
26	I think KOSP needs a little more than work in marketing...lol Anyways, I'm	Jeff Briley	-	11/12/1997
25	I think KOSP needs more work in marketing. Two internists in my office have no	Tom D	-	11/12/1997
24	Thanks for the response. I will check out Fuisz. I would love your opinion on	NY0001	-	10/28/1997
23	I am working on your request. I have e-mailed a request for data about Cardior	Tom D	-	10/25/1997
22	Can anyone tell me how KOS' valuation and technology compare other companie	NY0001	-	10/24/1997
21	I am optimistic. I honestly don't have the tools to make a meaningful pr	Tom D	-	10/9/1997
20	Tom, As a clinician, how do you foresee market share shaping up for KOSP? Can	James Silverman	-	10/9/1997
19	<<as old as the hills and available in health food stores>> 1) Nia	Tom D	-	10/6/1997

Go to reply# or date (mm/dd/yy):